Clinical Trial Update: Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study evaluating BRIMOCHOL PF and Carbachol PF for presbyopia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• BRIMOCHOL PF (carbachol)
• Carbachol PF (carbachol)

Snippet

Sponsor: Visus Therapeutics | Conditions: Presbyopia | Phase 3 | Status: COMPLETED